Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-23

Clinical Trial Update: Effect of Nasal Spray Dexmedetomidine on Emergence Delirium Prevention in Total Hip Replacement [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating recruitment for nasal spray dexmedetomidine to prevent emergence delirium following total hip replacement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine nasal spray (dexmedetomidine)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Delirium | Phase 4 | Status: RECRUITING